Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Asia Pacific Biobanking Market Outlook

The global biobanking market size was valued at USD 72.1 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the increased investments from both government and private sectors in biobanking. It is expected to grow at a CAGR of 6.89% during the forecast period of 2024-2032, with the values likely to attain USD 131.1 billion by 2032.

Key Takeaways

  • Asia Pacific is reported to have a high prevalence of chronic diseases, with the data revealing that 1 in every 4 people in India has a risk  of dying from a noncommunicable disease. This rising burden of chronic disease is expected to stimulate the development of novel drugs, thereby impacting the market demand.
  • In July 2023, CU Medicine successfully established the CU-Med Biobank , an internationally accredited biobank in Hong Kong, which is expected to turn it into an important biomedical research hub. The increased investment in the establishment of biobanks is likely to augment the Asia Pacific biobanking market share.
  • The increased recognition of biobanks as a valuable resource for researchers to study the disease onset and progression is elevating the market value. In November 2023, an INR 20 crore biobank was launched in South India, the third such facility  in India, to serve as a repository for collaborative research initiatives to map the prevention and reversal of diseases, among others.

Asia Pacific Biobanking Market Analysis

The practice of collecting, preserving, and managing biological samples such as blood, DNA, and tissues, among others, is defined as biobanking. The primary purpose of biobanks is to provide a reliable resource for medical research and development. These specialized facilities act as a repository for biological samples often needed for genetic analysis and biomarker discovery, thus supporting the advancement of personalized treatment therapies. The growing emphasis on genetic research and personalized medicine is significantly contributing to the Asia Pacific biobanking market growth.

The rising burden of chronic diseases has a profound influence on market dynamics. Asia Pacific is reported to have a high prevalence of these chronic conditions, with data revealing that 1 in every 4 people in India are at a risk of dying from a noncommunicable disease such as cancer, diabetes, and cardiovascular disease . Since biobanks are a prerequisite for developing new drugs and advanced diagnostic technologies. Consequently, the demand for these repositories is expected to grow with the rise in chronic disease cases.

One of the major Asia Pacific biobanking market trends is the increased investment in infrastructure development and establishment of biobanks. In July 2023, CU Medicine (Faculty of Medicine, The Chinese University of Hong Kong) successfully established the CU-Med Biobank , an internationally accredited biobank, expected to turn Hong Kong into an important biomedical research hub. The biobank is increasingly used for large-scale genomic research and is likely to attract collaborations from leading pharmaceutical companies and research institutes, thereby elevating the market value in the region.

The growing recognition of biobanks as a valuable resource for researchers to study the onset and progression of diseases is boosting the Asia Pacific biobanking market demand. In November 2023, an INR 20 crore state-of-the-art biobank was launched in South India, the third such facility  in the region to serve as a repository for collaborative research initiatives to map the prevention and reversal of diseases, among others. The biobank boasts 23 freezers with a capacity to store over 3 lakh samples. Such advanced biobanks are poised to accelerate innovation in the healthcare sector, ultimately propelling market growth in the coming years.

Asia Pacific Biobanking Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup Categories
Product and Service Equipment, Consumables, Service, Software
Application Regenerative Medicine, Life Science Research, Clinical Research
Sample Type Blood Tissue, Nucleic Acids, Cell Lines
End User Academic Institutions, Pharma and Biotech Companies
Country China, Japan, India, ASEAN, Australia, Others

Asia Pacific Biobanking Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Merck KGaA
  • Avantor, Inc.
  • Cryoport, Inc.
  • Tecan Trading AG
  • Lifecode Technologies Pte Ltd
  • China Cord Blood Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Service
  • Application
  • Sample Type
  • End User
  • Region
Breakup by Product and Service
  • Equipment
  • Consumables
  • Service
  • Software
Breakup by Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
Breakup by Sample Type
  • Blood Tissue
  • Nucleic Acids
  • Cell Lines
Breakup by End User
  • Academic Institutions
  • Pharma and Biotech Companies
Breakup by Region
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Merck KGaA 
  • Avantor, Inc.
  • Cryoport, Inc. 
  • Tecan Trading AG
  • Lifecode Technologies Pte Ltd 
  • China Cord Blood Corporation 

Asia Pacific Biobanking  Market Report Snapshots

Asia Pacific Biobanking Market Size

Asia Pacific Biobanking Market Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The Asia Pacific biobanking market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 6.89% during the forecast period of 2024-2032 and is likely to reach a market value of USD 131.1 billion by 2032.

The rising emphasis on the advancement of genetic research and personalized medicine along with increasing medical research expenditure is fuelling the demand for the market.

One of the significant trends in the market is the increased investment in the establishment of biobanks. In July 2023, CU Medicine successfully established the CU-Med Biobank in Hong Kong, which is expected to turn into an important biomedical research hub in the region.

Based on the products and services, the market is segmented into equipment, consumables, services, and software.

By sample type, the market is divided into blood tissue, nucleic acids, and cell lines.

End users of the market are academic institutions, pharma, and biotech companies.

Major application areas include regenerative medicine, life science research, and clinical research.

The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.

The key players in the market are PHC Holdings Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QIAGEN N.V., Merck KGaA, Avantor, Inc., Cryoport, Inc., Tecan Trading AG, Lifecode Technologies Pte Ltd, and China Cord Blood Corporation.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,299

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 4,899

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 5,899

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124